PTC today announced advancements to its application lifecycle management (ALM) portfolio with the release of the Codebeamer® 3.2, Codebeamer AI 1.0, and Pure Variantstm 7.2 solutions. These updates ...

More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US. The FDA has approved PTC's ...

PTC Therapeutic's Upstaza gene therapy for patients with genetic disorder AADC deficiency has been recommended for approval in the EU, setting up another test of the commercial prospects for gene ...

PTC India Limited (PTC) is a provider of power trading solutions in India. The Company is engaged in investing in equity or extending debt to power projects in generation, transmission, distribution, ...

PTC Industries Limited is an India-based company, which is engaged in manufacturing of precision metal components for critical applications. It is primarily engaged in the manufacturing of metal ...

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Get the detailed quarterly/annual income statement for PTC Therapeutics, Inc. (PTCT). Find out the revenue, expenses and profit or loss over the last fiscal year.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.